News
Media/Articles
News
- Exxel Pharma Participates in the Virtual Investor “Top 5 for ‘25” On-Demand Conference
- Exxel Pharma’s Innovative Small Molecule, EX937, Rapidly Advancing Toward First-In-Human Study for the Treatment of Refractory Chronic Cough
- Exxel Pharma to Participate in a “New to Virtual Investor” Segment
- Exxel’s CSO Daniele Piomelli receives Entrepreneurial Leader of the Year award from UC Irvine (UCI) Beall Applied Innovation